Repository logo

Views for Phase I safety and immunogenicity evaluations of an alphavirus replicon HIV-1 subtype C gag vaccine in healthy HIV-1-uninfected adults.

Total visits

views
Phase I safety and immunogenicity evaluations of an alphavirus replicon HIV-1 subtype C gag vaccine in healthy HIV-1-uninfected adults. 301

Total visits per month

views
February 2024 0
March 2024 0
April 2024 0
May 2024 0
June 2024 0
July 2024 0
August 2024 0

File Visits

views
Wecker_M_2012.pdf 258
Wecker_M_2012.pdf(legacy) 63

Top country views

views
United States 149
South Africa 48
Sweden 26
Germany 16
Vietnam 9
China 8
Netherlands 8
Ireland 6
Finland 4
Russia 3
Singapore 3
Brazil 2
Canada 2
India 2
France 1
Iraq 1
South Korea 1
Pakistan 1
Poland 1

Top city views

views
Ashburn 79
Johannesburg 20
Des Moines 10
Hanoi 9
Dublin 6
Andover 4
Pretoria 4
Washington 4
Bengaluru 2
Cape Town 2
Mountain View 2
Santa Clara 2
Seattle 2
Chizhou 1
Denver 1
Heidelberg 1
Karachi 1
Rio de Janeiro 1
Secaucus 1
Singapore 1
Stellenbosch 1
São Paulo 1
Tzaneen 1
Villieria 1
West Palm Beach 1